This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Brendan J. Duke | |
|---|---|
| Name | Brendan J. Duke |
| Birth date | 1978 |
| Birth place | Boston, Massachusetts, U.S. |
| Occupation | Researcher, academic, author |
| Alma mater | Harvard University; Massachusetts Institute of Technology |
| Known for | Molecular oncology; translational therapeutics |
Brendan J. Duke is an American researcher and academic known for work in molecular oncology and translational therapeutics. He has held positions at major research institutions and contributed to literature intersecting cancer biology, pharmacology, and bioinformatics. Duke's work bridges laboratory investigation and clinical application, collaborating with investigators across universities and healthcare systems.
Duke was born in Boston and attended Boston Latin School before matriculating at Harvard University where he studied molecular biology and chemistry. He pursued doctoral study at the Massachusetts Institute of Technology under advisors affiliated with the Broad Institute and conducted postdoctoral training at the Dana–Farber Cancer Institute in collaboration with researchers at Brigham and Women's Hospital. During training he interacted with scientists from the Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, and the Salk Institute, and participated in programs hosted by the National Institutes of Health and the Wellcome Trust. His education included coursework and seminars featuring faculty from Stanford University, University of California, San Francisco, and Johns Hopkins University.
Duke began his independent career at a research center affiliated with Massachusetts General Hospital and later joined a faculty appointment at a major public university influenced by colleagues from University of California, Berkeley, University of Chicago, and Yale University. He has held visiting scientist roles at the European Molecular Biology Laboratory and collaborative appointments with investigators at Oxford University and Cambridge University. Duke's career includes consulting with teams at pharmaceutical companies such as Pfizer, Novartis, and Roche, and partnerships with biotechnology firms including Genentech, Amgen, and Biogen. He has served on grant review panels for the National Cancer Institute, advisory boards for the American Association for Cancer Research, and editorial boards for journals tied to the Nature Publishing Group and the American Association for the Advancement of Science.
Duke's research combines experimental oncology with computational analysis, producing studies that cite work from investigators at Memorial Sloan Kettering Cancer Center, Fred Hutchinson Cancer Center, and MD Anderson Cancer Center. His laboratory developed models integrating datasets from The Cancer Genome Atlas, ENCODE Project, and the 1000 Genomes Project to identify targets validated using techniques derived from protocols at Addgene, Thermo Fisher Scientific, and Agilent Technologies. He published reports describing interactions between signaling pathways characterized in studies from Cold Spring Harbor Laboratory and structural insights paralleling methods used at the European Bioinformatics Institute and Protein Data Bank. Duke contributed to translational pipelines similar to those at Translational Research Institute, enabling collaborations with clinical trials teams at Mayo Clinic, Cleveland Clinic, and Johns Hopkins Hospital. His interdisciplinary teams worked alongside investigators associated with Broad Institute programmers, Carnegie Institution for Science computational groups, and consortia including the Human Cell Atlas and the International Cancer Genome Consortium.
Duke's honors include awards from organizations modeled on the American Cancer Society, fellowships comparable to those from the Gordon and Betty Moore Foundation and the Helen Hay Whitney Foundation, and recognition by academies akin to the National Academy of Medicine and the Royal Society. He received grant funding through programs affiliated with the Howard Hughes Medical Institute and prizes presented at symposia sponsored by the American Association for Cancer Research and the European Society for Medical Oncology. Duke was invited to lecture at conferences organized by Cold Spring Harbor Laboratory, Keystone Symposia, and the Gordon Research Conferences.
Duke lives in the Boston area and is active in outreach programs connected to institutions such as Harvard Medical School, Boston Children's Hospital, and local chapters of American Red Cross. He participates in collaborative community science initiatives with partners from Massachusetts Institute of Technology alumni networks, regional programs affiliated with United Way, and mentoring schemes run by organizations like Society for Neuroscience and the Association of American Medical Colleges.
Category:Living people Category:American scientists